Letter

The GMC: expediency before principle

BMJ 2005; 330 doi: 10.1136/bmj.330.7485.253-b (Published 27 January 2005)
Cite this as: BMJ 2005;330:253.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Proceed with caution

  1. Stephen F Hayes (stephen.hayes1@virgin.net), freelance general practi
  1. Botley, Hampshire SO30 2AA

EDITOR—When a new drug is introduced, three questions must be asked and as far as possible answered before it comes into widespread use:

  1. Does it work for the condition in question?

  2. Is it safe? (In particular, are there any potential side effects that may be worse than the disease?)

  3. Is it affordable?

The drug must also be compared with other agents and …

Access to the full text of this article requires a subscription or payment

Subscribe

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

Rapid responses

THIS WEEK'S POLL

BMJ most popular